Evidence map›Paper›PMID 29270747›Full record

ArticleJournal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban2017

Knockdown of GRHL3 inhibits activities and induces cell cycle arrest and apoptosis of human colorectal cancer cells.

Xiao-Kang Wang, Fen-Fang Zhou, Hao-Ran Tao, Xin Wang, Chi Zhang, Fei Su, Shi-Pei Wang, Li-Hua Xu, Xue-Kai Pan, Mao-Hui Feng and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. A large-scale cancer-specific protein-DNA interaction network.bioRxiv : the preprint server for biology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Grainyhead-like transcription factors in cancer - Focus on recent developments.Experimental biology and medicine (Maywood, N.J.) · 2020
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Xiao-Kang WangDepartment of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Fen-Fang ZhouDepartment of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Hao-Ran TaoSchool of Clinical Medicine, Fenyang Medical College, Shanxi Medical University, Fenyang, 032200, China.
Xin WangDepartment of General Surgery, Tongshan Renmin Hospital, Tongshan, 437400, China.
Chi ZhangDepartment of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Fei SuDepartment of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Shi-Pei WangDepartment of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Li-Hua XuDepartment of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Xue-Kai PanDepartment of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Mao-Hui FengDepartment of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. fengmh5690@163.com.
Wei XieDepartment of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. xiewei5807@163.com.
Wuhan University · CNZhongnan Hospital of Wuhan University · CNShanxi Fenyang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Grainyhead-like 3 (GRHL3) is involved in epidermal barrier formation, neural tube closure and wound repair. Previous studies have suggested that GRHL3 has been linked to many different types of cancers. However, to date, its effects on human colorectal cancer (CRC) has not been clarified yet. Our microarray analysis has indicated predominant GRHL3 expression in CRC. The purpose of this study was to investigate the expression and significance of GRHL3 in CRC tumorigenesis using CRC tissues and paired paracancerous tissues, as well as using distinct CRC cell lines (HT29 and DLD1). We observed increased GRHL3 expression at both mRNA and protein levels in CRC tissues and CRC cell lines using quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting. Moreover, silencing GRHL3 with siRNA could suppress CRC cell proliferation, viability and migration in vitro. We also found that knockdown of GRHL3 could promote cell cycle arrest at G

Indexed as

Gene Expression Regulation, NeoplasticApoptosisCell Cycle CheckpointsCell Line, TumorCell MovementCell ProliferationColorectal NeoplasmsDNA-Binding ProteinsGene Expression ProfilingHCT116 CellsHT29 CellsHumansMicroarray AnalysisRNA, Small InterferingTranscription FactorsDNA-Binding ProteinsGRHL3 protein, humanRNA, Small InterferingTranscription Factorsapoptosiscell cyclecolorectal cancerGrainyhead-like 3migrationproliferation

Identifiers

PMID29270747
OpenAlexW2783940941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.